カテゴリー： LP Information, 世界, 部品/材料

世界のレシヌラド市場予測 2023年-2029年

◆英語タイトル：Global Lesinurad Market Growth 2023-2029
	◆商品コード：LP23JU0291 ◆発行会社（リサーチ会社）：LP Information ◆発行日：2023年5月 ◆ページ数：108 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など ◆産業分野：化学＆材料

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,660 ⇒換算￥556,320	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,490 ⇒換算￥834,480	見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）	USD7,320 ⇒換算￥1,112,640	見積依頼/購入/質問フォーム

★LP Informationに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のレシヌラド市場」は、過去の販売実績から2022年の世界のレシヌラドの総販売量を検討し、2023年から2029年の予測されるレシヌラドの販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のレシヌラドの市場規模を掲載し、XXX百万米ドル規模の世界のレシヌラド市場の詳細な分析を提供します。本インサイトレポートは、世界のレシヌラド業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のレシヌラド市場における各社の独自のポジションをより深く理解するために、レシヌラド製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のレシヌラド市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。レシヌラドの米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。レシヌラドの中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。レシヌラドのヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

レシヌラドの世界主要メーカーとしては、AbMole BioScience、 Ausun Pharmaceutical、 Cayman Chemical、 MedKoo Biosciences、 Clearsynth、 Target Mol、 UQUIFA、 MSN Labs、 CHEMO、 Nifty Labs、 Manus Aktteva Biopharma LLP、 Vcare Pharmatech、 Meso Chemなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のレシヌラド市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではレシヌラド市場をセグメンテーションし、種類別 (純度98%以上、純度99%以上)、用途別 (研究機関、製薬企業、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：純度98%以上、純度99%以上

・用途別区分：研究機関、製薬企業、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界のレシヌラド市場の10年間の市場状況・展望は？
・世界および地域別に見たレシヌラド市場成長の要因は何か？
・レシヌラドの市場機会はエンドマーケットの規模によってどのように変化するのか？
・レシヌラドのタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：レシヌラドの年間販売量2018-2029、地域別現状・将来分析
・レシヌラドの種類別セグメント：純度98%以上、純度99%以上
・レシヌラドの種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・レシヌラドの用途別セグメント：研究機関、製薬企業、その他
・レシヌラドの用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のレシヌラド市場
・企業別のグローバルレシヌラド市場データ：2018-2023年の年間販売量、市場シェア
・企業別のレシヌラドの年間売上：2018-2023年の売上、市場シェア
・企業別のレシヌラド販売価格
・主要企業のレシヌラド生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

レシヌラドの地域別レビュー
・地域別のレシヌラド市場規模2018-2023：年間販売量、売上
・主要国別のレシヌラド市場規模2018-2023：年間販売量、売上
・南北アメリカのレシヌラド販売の成長
・アジア太平洋のレシヌラド販売の成長
・ヨーロッパのレシヌラド販売の成長
・中東・アフリカのレシヌラド販売の成長

南北アメリカ市場
・南北アメリカの国別のレシヌラド販売量、売上（2018-2023）
・南北アメリカのレシヌラドの種類別販売量
・南北アメリカのレシヌラドの用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のレシヌラド販売量、売上（2018-2023）
・アジア太平洋のレシヌラドの種類別販売量
・アジア太平洋のレシヌラドの用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のレシヌラド販売量、売上（2018-2023）
・ヨーロッパのレシヌラドの種類別販売量
・ヨーロッパのレシヌラドの用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のレシヌラド販売量、売上（2018-2023）
・中東・アフリカのレシヌラドの種類別販売量
・中東・アフリカのレシヌラドの用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・レシヌラドの製造コスト構造分析
・レシヌラドの製造プロセス分析
・レシヌラドの産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・レシヌラドの主要なグローバル販売業者
・レシヌラドの主要なグローバル顧客

地域別のレシヌラド市場予測レビュー
・地域別のレシヌラド市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・レシヌラドの種類別市場規模予測
・レシヌラドの用途別市場規模予測

主要企業分析
AbMole BioScience、 Ausun Pharmaceutical、 Cayman Chemical、 MedKoo Biosciences、 Clearsynth、 Target Mol、 UQUIFA、 MSN Labs、 CHEMO、 Nifty Labs、 Manus Aktteva Biopharma LLP、 Vcare Pharmatech、 Meso Chem
・企業情報
・レシヌラド製品
・レシヌラド販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

Lesinurad, also known as RDEA594, is a selective uric acid re-absorption inhibitor (SURI) and is also a selective inhibitor of URAT1, a transporter in the kidney that regulates uric acid excretion from the body.
LPI (LP Information)’ newest research report, the “Lesinurad Industry Forecast” looks at past sales and reviews total world Lesinurad sales in 2022, providing a comprehensive analysis by region and market sector of projected Lesinurad sales for 2023 through 2029. With Lesinurad sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Lesinurad industry.
This Insight Report provides a comprehensive analysis of the global Lesinurad landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Lesinurad portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Lesinurad market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Lesinurad and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Lesinurad.
The global Lesinurad market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Lesinurad is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Lesinurad is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Lesinurad is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Lesinurad players cover AbMole BioScience, Ausun Pharmaceutical, Cayman Chemical, MedKoo Biosciences, Clearsynth, Target Mol, UQUIFA, MSN Labs and CHEMO, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Lesinurad market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Purity ≥ 98 %
Purity ≥ 99 %
Segmentation by application
Research Institute
Pharmaceutical
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
AbMole BioScience
Ausun Pharmaceutical
Cayman Chemical
MedKoo Biosciences
Clearsynth
Target Mol
UQUIFA
MSN Labs
CHEMO
Nifty Labs
Manus Aktteva Biopharma LLP
Vcare Pharmatech
Meso Chem
Key Questions Addressed in this Report
What is the 10-year outlook for the global Lesinurad market?
What factors are driving Lesinurad market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Lesinurad market opportunities vary by end market size?
How does Lesinurad break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Lesinurad Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Lesinurad by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Lesinurad by Country/Region, 2018, 2022 & 2029
2.2 Lesinurad Segment by Type
2.2.1 Purity ≥ 98 %
2.2.2 Purity ≥ 99 %
2.3 Lesinurad Sales by Type
2.3.1 Global Lesinurad Sales Market Share by Type (2018-2023)
2.3.2 Global Lesinurad Revenue and Market Share by Type (2018-2023)
2.3.3 Global Lesinurad Sale Price by Type (2018-2023)
2.4 Lesinurad Segment by Application
2.4.1 Research Institute
2.4.2 Pharmaceutical
2.4.3 Others
2.5 Lesinurad Sales by Application
2.5.1 Global Lesinurad Sale Market Share by Application (2018-2023)
2.5.2 Global Lesinurad Revenue and Market Share by Application (2018-2023)
2.5.3 Global Lesinurad Sale Price by Application (2018-2023)
3 Global Lesinurad by Company
3.1 Global Lesinurad Breakdown Data by Company
3.1.1 Global Lesinurad Annual Sales by Company (2018-2023)
3.1.2 Global Lesinurad Sales Market Share by Company (2018-2023)
3.2 Global Lesinurad Annual Revenue by Company (2018-2023)
3.2.1 Global Lesinurad Revenue by Company (2018-2023)
3.2.2 Global Lesinurad Revenue Market Share by Company (2018-2023)
3.3 Global Lesinurad Sale Price by Company
3.4 Key Manufacturers Lesinurad Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Lesinurad Product Location Distribution
3.4.2 Players Lesinurad Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Lesinurad by Geographic Region
4.1 World Historic Lesinurad Market Size by Geographic Region (2018-2023)
4.1.1 Global Lesinurad Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Lesinurad Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Lesinurad Market Size by Country/Region (2018-2023)
4.2.1 Global Lesinurad Annual Sales by Country/Region (2018-2023)
4.2.2 Global Lesinurad Annual Revenue by Country/Region (2018-2023)
4.3 Americas Lesinurad Sales Growth
4.4 APAC Lesinurad Sales Growth
4.5 Europe Lesinurad Sales Growth
4.6 Middle East & Africa Lesinurad Sales Growth
5 Americas
5.1 Americas Lesinurad Sales by Country
5.1.1 Americas Lesinurad Sales by Country (2018-2023)
5.1.2 Americas Lesinurad Revenue by Country (2018-2023)
5.2 Americas Lesinurad Sales by Type
5.3 Americas Lesinurad Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Lesinurad Sales by Region
6.1.1 APAC Lesinurad Sales by Region (2018-2023)
6.1.2 APAC Lesinurad Revenue by Region (2018-2023)
6.2 APAC Lesinurad Sales by Type
6.3 APAC Lesinurad Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Lesinurad by Country
7.1.1 Europe Lesinurad Sales by Country (2018-2023)
7.1.2 Europe Lesinurad Revenue by Country (2018-2023)
7.2 Europe Lesinurad Sales by Type
7.3 Europe Lesinurad Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Lesinurad by Country
8.1.1 Middle East & Africa Lesinurad Sales by Country (2018-2023)
8.1.2 Middle East & Africa Lesinurad Revenue by Country (2018-2023)
8.2 Middle East & Africa Lesinurad Sales by Type
8.3 Middle East & Africa Lesinurad Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Lesinurad
10.3 Manufacturing Process Analysis of Lesinurad
10.4 Industry Chain Structure of Lesinurad
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Lesinurad Distributors
11.3 Lesinurad Customer
12 World Forecast Review for Lesinurad by Geographic Region
12.1 Global Lesinurad Market Size Forecast by Region
12.1.1 Global Lesinurad Forecast by Region (2024-2029)
12.1.2 Global Lesinurad Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Lesinurad Forecast by Type
12.7 Global Lesinurad Forecast by Application
13 Key Players Analysis
13.1 AbMole BioScience
13.1.1 AbMole BioScience Company Information
13.1.2 AbMole BioScience Lesinurad Product Portfolios and Specifications
13.1.3 AbMole BioScience Lesinurad Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 AbMole BioScience Main Business Overview
13.1.5 AbMole BioScience Latest Developments
13.2 Ausun Pharmaceutical
13.2.1 Ausun Pharmaceutical Company Information
13.2.2 Ausun Pharmaceutical Lesinurad Product Portfolios and Specifications
13.2.3 Ausun Pharmaceutical Lesinurad Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Ausun Pharmaceutical Main Business Overview
13.2.5 Ausun Pharmaceutical Latest Developments
13.3 Cayman Chemical
13.3.1 Cayman Chemical Company Information
13.3.2 Cayman Chemical Lesinurad Product Portfolios and Specifications
13.3.3 Cayman Chemical Lesinurad Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Cayman Chemical Main Business Overview
13.3.5 Cayman Chemical Latest Developments
13.4 MedKoo Biosciences
13.4.1 MedKoo Biosciences Company Information
13.4.2 MedKoo Biosciences Lesinurad Product Portfolios and Specifications
13.4.3 MedKoo Biosciences Lesinurad Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 MedKoo Biosciences Main Business Overview
13.4.5 MedKoo Biosciences Latest Developments
13.5 Clearsynth
13.5.1 Clearsynth Company Information
13.5.2 Clearsynth Lesinurad Product Portfolios and Specifications
13.5.3 Clearsynth Lesinurad Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Clearsynth Main Business Overview
13.5.5 Clearsynth Latest Developments
13.6 Target Mol
13.6.1 Target Mol Company Information
13.6.2 Target Mol Lesinurad Product Portfolios and Specifications
13.6.3 Target Mol Lesinurad Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Target Mol Main Business Overview
13.6.5 Target Mol Latest Developments
13.7 UQUIFA
13.7.1 UQUIFA Company Information
13.7.2 UQUIFA Lesinurad Product Portfolios and Specifications
13.7.3 UQUIFA Lesinurad Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 UQUIFA Main Business Overview
13.7.5 UQUIFA Latest Developments
13.8 MSN Labs
13.8.1 MSN Labs Company Information
13.8.2 MSN Labs Lesinurad Product Portfolios and Specifications
13.8.3 MSN Labs Lesinurad Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 MSN Labs Main Business Overview
13.8.5 MSN Labs Latest Developments
13.9 CHEMO
13.9.1 CHEMO Company Information
13.9.2 CHEMO Lesinurad Product Portfolios and Specifications
13.9.3 CHEMO Lesinurad Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 CHEMO Main Business Overview
13.9.5 CHEMO Latest Developments
13.10 Nifty Labs
13.10.1 Nifty Labs Company Information
13.10.2 Nifty Labs Lesinurad Product Portfolios and Specifications
13.10.3 Nifty Labs Lesinurad Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Nifty Labs Main Business Overview
13.10.5 Nifty Labs Latest Developments
13.11 Manus Aktteva Biopharma LLP
13.11.1 Manus Aktteva Biopharma LLP Company Information
13.11.2 Manus Aktteva Biopharma LLP Lesinurad Product Portfolios and Specifications
13.11.3 Manus Aktteva Biopharma LLP Lesinurad Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Manus Aktteva Biopharma LLP Main Business Overview
13.11.5 Manus Aktteva Biopharma LLP Latest Developments
13.12 Vcare Pharmatech
13.12.1 Vcare Pharmatech Company Information
13.12.2 Vcare Pharmatech Lesinurad Product Portfolios and Specifications
13.12.3 Vcare Pharmatech Lesinurad Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Vcare Pharmatech Main Business Overview
13.12.5 Vcare Pharmatech Latest Developments
13.13 Meso Chem
13.13.1 Meso Chem Company Information
13.13.2 Meso Chem Lesinurad Product Portfolios and Specifications
13.13.3 Meso Chem Lesinurad Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Meso Chem Main Business Overview
13.13.5 Meso Chem Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Lesinurad Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Lesinurad Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Purity ≥ 98 %
Table 4. Major Players of Purity ≥ 99 %
Table 5. Global Lesinurad Sales by Type (2018-2023) & (Tons)
Table 6. Global Lesinurad Sales Market Share by Type (2018-2023)
Table 7. Global Lesinurad Revenue by Type (2018-2023) & ($ million)
Table 8. Global Lesinurad Revenue Market Share by Type (2018-2023)
Table 9. Global Lesinurad Sale Price by Type (2018-2023) & (US$/Ton)
Table 10. Global Lesinurad Sales by Application (2018-2023) & (Tons)
Table 11. Global Lesinurad Sales Market Share by Application (2018-2023)
Table 12. Global Lesinurad Revenue by Application (2018-2023)
Table 13. Global Lesinurad Revenue Market Share by Application (2018-2023)
Table 14. Global Lesinurad Sale Price by Application (2018-2023) & (US$/Ton)
Table 15. Global Lesinurad Sales by Company (2018-2023) & (Tons)
Table 16. Global Lesinurad Sales Market Share by Company (2018-2023)
Table 17. Global Lesinurad Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Lesinurad Revenue Market Share by Company (2018-2023)
Table 19. Global Lesinurad Sale Price by Company (2018-2023) & (US$/Ton)
Table 20. Key Manufacturers Lesinurad Producing Area Distribution and Sales Area
Table 21. Players Lesinurad Products Offered
Table 22. Lesinurad Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Lesinurad Sales by Geographic Region (2018-2023) & (Tons)
Table 26. Global Lesinurad Sales Market Share Geographic Region (2018-2023)
Table 27. Global Lesinurad Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Lesinurad Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Lesinurad Sales by Country/Region (2018-2023) & (Tons)
Table 30. Global Lesinurad Sales Market Share by Country/Region (2018-2023)
Table 31. Global Lesinurad Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Lesinurad Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Lesinurad Sales by Country (2018-2023) & (Tons)
Table 34. Americas Lesinurad Sales Market Share by Country (2018-2023)
Table 35. Americas Lesinurad Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Lesinurad Revenue Market Share by Country (2018-2023)
Table 37. Americas Lesinurad Sales by Type (2018-2023) & (Tons)
Table 38. Americas Lesinurad Sales by Application (2018-2023) & (Tons)
Table 39. APAC Lesinurad Sales by Region (2018-2023) & (Tons)
Table 40. APAC Lesinurad Sales Market Share by Region (2018-2023)
Table 41. APAC Lesinurad Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Lesinurad Revenue Market Share by Region (2018-2023)
Table 43. APAC Lesinurad Sales by Type (2018-2023) & (Tons)
Table 44. APAC Lesinurad Sales by Application (2018-2023) & (Tons)
Table 45. Europe Lesinurad Sales by Country (2018-2023) & (Tons)
Table 46. Europe Lesinurad Sales Market Share by Country (2018-2023)
Table 47. Europe Lesinurad Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Lesinurad Revenue Market Share by Country (2018-2023)
Table 49. Europe Lesinurad Sales by Type (2018-2023) & (Tons)
Table 50. Europe Lesinurad Sales by Application (2018-2023) & (Tons)
Table 51. Middle East & Africa Lesinurad Sales by Country (2018-2023) & (Tons)
Table 52. Middle East & Africa Lesinurad Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Lesinurad Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Lesinurad Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Lesinurad Sales by Type (2018-2023) & (Tons)
Table 56. Middle East & Africa Lesinurad Sales by Application (2018-2023) & (Tons)
Table 57. Key Market Drivers & Growth Opportunities of Lesinurad
Table 58. Key Market Challenges & Risks of Lesinurad
Table 59. Key Industry Trends of Lesinurad
Table 60. Lesinurad Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Lesinurad Distributors List
Table 63. Lesinurad Customer List
Table 64. Global Lesinurad Sales Forecast by Region (2024-2029) & (Tons)
Table 65. Global Lesinurad Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Lesinurad Sales Forecast by Country (2024-2029) & (Tons)
Table 67. Americas Lesinurad Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Lesinurad Sales Forecast by Region (2024-2029) & (Tons)
Table 69. APAC Lesinurad Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Lesinurad Sales Forecast by Country (2024-2029) & (Tons)
Table 71. Europe Lesinurad Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Lesinurad Sales Forecast by Country (2024-2029) & (Tons)
Table 73. Middle East & Africa Lesinurad Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Lesinurad Sales Forecast by Type (2024-2029) & (Tons)
Table 75. Global Lesinurad Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Lesinurad Sales Forecast by Application (2024-2029) & (Tons)
Table 77. Global Lesinurad Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. AbMole BioScience Basic Information, Lesinurad Manufacturing Base, Sales Area and Its Competitors
Table 79. AbMole BioScience Lesinurad Product Portfolios and Specifications
Table 80. AbMole BioScience Lesinurad Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 81. AbMole BioScience Main Business
Table 82. AbMole BioScience Latest Developments
Table 83. Ausun Pharmaceutical Basic Information, Lesinurad Manufacturing Base, Sales Area and Its Competitors
Table 84. Ausun Pharmaceutical Lesinurad Product Portfolios and Specifications
Table 85. Ausun Pharmaceutical Lesinurad Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 86. Ausun Pharmaceutical Main Business
Table 87. Ausun Pharmaceutical Latest Developments
Table 88. Cayman Chemical Basic Information, Lesinurad Manufacturing Base, Sales Area and Its Competitors
Table 89. Cayman Chemical Lesinurad Product Portfolios and Specifications
Table 90. Cayman Chemical Lesinurad Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 91. Cayman Chemical Main Business
Table 92. Cayman Chemical Latest Developments
Table 93. MedKoo Biosciences Basic Information, Lesinurad Manufacturing Base, Sales Area and Its Competitors
Table 94. MedKoo Biosciences Lesinurad Product Portfolios and Specifications
Table 95. MedKoo Biosciences Lesinurad Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 96. MedKoo Biosciences Main Business
Table 97. MedKoo Biosciences Latest Developments
Table 98. Clearsynth Basic Information, Lesinurad Manufacturing Base, Sales Area and Its Competitors
Table 99. Clearsynth Lesinurad Product Portfolios and Specifications
Table 100. Clearsynth Lesinurad Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 101. Clearsynth Main Business
Table 102. Clearsynth Latest Developments
Table 103. Target Mol Basic Information, Lesinurad Manufacturing Base, Sales Area and Its Competitors
Table 104. Target Mol Lesinurad Product Portfolios and Specifications
Table 105. Target Mol Lesinurad Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 106. Target Mol Main Business
Table 107. Target Mol Latest Developments
Table 108. UQUIFA Basic Information, Lesinurad Manufacturing Base, Sales Area and Its Competitors
Table 109. UQUIFA Lesinurad Product Portfolios and Specifications
Table 110. UQUIFA Lesinurad Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 111. UQUIFA Main Business
Table 112. UQUIFA Latest Developments
Table 113. MSN Labs Basic Information, Lesinurad Manufacturing Base, Sales Area and Its Competitors
Table 114. MSN Labs Lesinurad Product Portfolios and Specifications
Table 115. MSN Labs Lesinurad Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 116. MSN Labs Main Business
Table 117. MSN Labs Latest Developments
Table 118. CHEMO Basic Information, Lesinurad Manufacturing Base, Sales Area and Its Competitors
Table 119. CHEMO Lesinurad Product Portfolios and Specifications
Table 120. CHEMO Lesinurad Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 121. CHEMO Main Business
Table 122. CHEMO Latest Developments
Table 123. Nifty Labs Basic Information, Lesinurad Manufacturing Base, Sales Area and Its Competitors
Table 124. Nifty Labs Lesinurad Product Portfolios and Specifications
Table 125. Nifty Labs Lesinurad Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 126. Nifty Labs Main Business
Table 127. Nifty Labs Latest Developments
Table 128. Manus Aktteva Biopharma LLP Basic Information, Lesinurad Manufacturing Base, Sales Area and Its Competitors
Table 129. Manus Aktteva Biopharma LLP Lesinurad Product Portfolios and Specifications
Table 130. Manus Aktteva Biopharma LLP Lesinurad Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 131. Manus Aktteva Biopharma LLP Main Business
Table 132. Manus Aktteva Biopharma LLP Latest Developments
Table 133. Vcare Pharmatech Basic Information, Lesinurad Manufacturing Base, Sales Area and Its Competitors
Table 134. Vcare Pharmatech Lesinurad Product Portfolios and Specifications
Table 135. Vcare Pharmatech Lesinurad Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 136. Vcare Pharmatech Main Business
Table 137. Vcare Pharmatech Latest Developments
Table 138. Meso Chem Basic Information, Lesinurad Manufacturing Base, Sales Area and Its Competitors
Table 139. Meso Chem Lesinurad Product Portfolios and Specifications
Table 140. Meso Chem Lesinurad Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 141. Meso Chem Main Business
Table 142. Meso Chem Latest Developments
List of Figures
Figure 1. Picture of Lesinurad
Figure 2. Lesinurad Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Lesinurad Sales Growth Rate 2018-2029 (Tons)
Figure 7. Global Lesinurad Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Lesinurad Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Purity ≥ 98 %
Figure 10. Product Picture of Purity ≥ 99 %
Figure 11. Global Lesinurad Sales Market Share by Type in 2022
Figure 12. Global Lesinurad Revenue Market Share by Type (2018-2023)
Figure 13. Lesinurad Consumed in Research Institute
Figure 14. Global Lesinurad Market: Research Institute (2018-2023) & (Tons)
Figure 15. Lesinurad Consumed in Pharmaceutical
Figure 16. Global Lesinurad Market: Pharmaceutical (2018-2023) & (Tons)
Figure 17. Lesinurad Consumed in Others
Figure 18. Global Lesinurad Market: Others (2018-2023) & (Tons)
Figure 19. Global Lesinurad Sales Market Share by Application (2022)
Figure 20. Global Lesinurad Revenue Market Share by Application in 2022
Figure 21. Lesinurad Sales Market by Company in 2022 (Tons)
Figure 22. Global Lesinurad Sales Market Share by Company in 2022
Figure 23. Lesinurad Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Lesinurad Revenue Market Share by Company in 2022
Figure 25. Global Lesinurad Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Lesinurad Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Lesinurad Sales 2018-2023 (Tons)
Figure 28. Americas Lesinurad Revenue 2018-2023 ($ Millions)
Figure 29. APAC Lesinurad Sales 2018-2023 (Tons)
Figure 30. APAC Lesinurad Revenue 2018-2023 ($ Millions)
Figure 31. Europe Lesinurad Sales 2018-2023 (Tons)
Figure 32. Europe Lesinurad Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Lesinurad Sales 2018-2023 (Tons)
Figure 34. Middle East & Africa Lesinurad Revenue 2018-2023 ($ Millions)
Figure 35. Americas Lesinurad Sales Market Share by Country in 2022
Figure 36. Americas Lesinurad Revenue Market Share by Country in 2022
Figure 37. Americas Lesinurad Sales Market Share by Type (2018-2023)
Figure 38. Americas Lesinurad Sales Market Share by Application (2018-2023)
Figure 39. United States Lesinurad Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Lesinurad Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Lesinurad Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Lesinurad Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Lesinurad Sales Market Share by Region in 2022
Figure 44. APAC Lesinurad Revenue Market Share by Regions in 2022
Figure 45. APAC Lesinurad Sales Market Share by Type (2018-2023)
Figure 46. APAC Lesinurad Sales Market Share by Application (2018-2023)
Figure 47. China Lesinurad Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Lesinurad Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Lesinurad Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Lesinurad Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Lesinurad Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Lesinurad Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Lesinurad Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Lesinurad Sales Market Share by Country in 2022
Figure 55. Europe Lesinurad Revenue Market Share by Country in 2022
Figure 56. Europe Lesinurad Sales Market Share by Type (2018-2023)
Figure 57. Europe Lesinurad Sales Market Share by Application (2018-2023)
Figure 58. Germany Lesinurad Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Lesinurad Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Lesinurad Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Lesinurad Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Lesinurad Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Lesinurad Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Lesinurad Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Lesinurad Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Lesinurad Sales Market Share by Application (2018-2023)
Figure 67. Egypt Lesinurad Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Lesinurad Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Lesinurad Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Lesinurad Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Lesinurad Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Lesinurad in 2022
Figure 73. Manufacturing Process Analysis of Lesinurad
Figure 74. Industry Chain Structure of Lesinurad
Figure 75. Channels of Distribution
Figure 76. Global Lesinurad Sales Market Forecast by Region (2024-2029)
Figure 77. Global Lesinurad Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Lesinurad Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Lesinurad Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Lesinurad Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Lesinurad Revenue Market Share Forecast by Application (2024-2029)

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のレシヌラド市場予測 2023年-2029年(Global Lesinurad Market Growth 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界のレシヌラド市場予測 2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp